AI Terminal
Atrato Onsite Energy PLC
Board/Management Information • Dec 23, 2022
5354_rns_2022-12-23_92bacdc5-e231-46cc-8158-ab9e1c6aa914.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8959K
Atrato Onsite Energy PLC
23 December 2022
23 December 2022
LEI: 213800IE1PPREDIIZB62
Atrato Onsite Energy plc
(the "Company")
Appointment of Joint Corporate Broker
Atrato Onsite Energy plc (LSE:ROOF), the renewables investment trust focusing on UK commercial onsite energy and providing investors with capital growth and long-dated, index-linked income, is pleased to announce the appointment of Berenberg as Joint Corporate Broker, alongside Alvarium Securities, with immediate effect.
Enquiries
| Atrato Partners Limited Gurpreet Gujral Francisca Wiggins Christopher Fearon |
[email protected] +44 (0)77 959 75560 |
| Alvarium Securities Limited Mark Thompson Eddie Nissen Oliver Kenyon |
+44 (0)20 7016 6711 +44 (0)20 7016 6713 +44 (0)20 7016 6704 |
| Joh. Berenberg, Gossler & Co. KG Gillian Martin Ben Wright Dan Gee-Summons |
+44 (0)20 3753 4980 |
| Kaso Legg Communications Limited Charles Gorman Millie Steyn |
[email protected] +44 (0)20 3995 6673 +44 (0)20 3995 6671 |
Notes to Editors
Atrato Onsite Energy plc is an investment company focused on clean energy generation, providing new renewable energy capacity with 100% carbon traceability to industrial and commercial counterparties. The Company focuses on UK commercial onsite solar, helping its corporate clients achieve net zero and reduce their energy bills. Its shares were admitted to trading on the premium segment of the Main Market of the London Stock Exchange on 23 November 2021. Atrato Partners Limited is the Company's investment adviser.
Further information is available on the Company's website, www.atratoroof.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPKZMZZRFRGZZG